GSK (LON:GSK) Price Target Lowered to GBX 1,850 at Deutsche Bank Aktiengesellschaft

GSK (LON:GSK) had its price objective reduced by Deutsche Bank Aktiengesellschaft from GBX 1,950 ($25.08) to GBX 1,850 ($23.80) in a research report report published on Wednesday, MarketBeat reports. They currently have a buy rating on the stock.

Several other research analysts have also recently issued reports on GSK. Jefferies Financial Group reissued a buy rating and issued a GBX 2,100 ($27.01) target price on shares of GSK in a research report on Thursday, June 27th. Shore Capital reissued a buy rating on shares of GSK in a report on Thursday, June 27th. JPMorgan Chase & Co. reaffirmed an underweight rating on shares of GSK in a report on Monday, July 29th. Barclays reiterated an equal weight rating and issued a GBX 1,725 ($22.19) price target on shares of GSK in a research report on Tuesday, May 7th. Finally, Citigroup cut their price objective on shares of GSK from GBX 2,120 ($27.27) to GBX 1,900 ($24.44) and set a buy rating for the company in a research report on Friday, July 5th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and an average price target of GBX 1,805.71 ($23.23).

GSK Stock Performance

GSK stock opened at GBX 1,562.50 ($20.10) on Wednesday. The company has a debt-to-equity ratio of 134.34, a current ratio of 0.87 and a quick ratio of 0.73. GSK has a 1 year low of GBX 1,330.19 ($17.11) and a 1 year high of GBX 1,823.50 ($23.46). The company has a market cap of £63.75 billion, a P/E ratio of 1,433.49, a price-to-earnings-growth ratio of 1.19 and a beta of 0.27. The stock’s fifty day moving average price is GBX 1,577.02 and its 200-day moving average price is GBX 1,635.71.

GSK Announces Dividend

The firm also recently declared a dividend, which will be paid on Thursday, October 10th. Shareholders of record on Thursday, August 15th will be paid a GBX 15 ($0.19) dividend. The ex-dividend date of this dividend is Thursday, August 15th. This represents a yield of 0.97%. GSK’s payout ratio is presently 5,504.59%.

Insider Activity

In other GSK news, insider Wendy Becker purchased 446 shares of the company’s stock in a transaction on Thursday, June 20th. The stock was acquired at an average cost of GBX 1,614 ($20.76) per share, for a total transaction of £7,198.44 ($9,259.63). Company insiders own 1.60% of the company’s stock.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.